Cliff Asness's USNA Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 296,420 shares of USANA Health Sciences, Inc. (USNA) worth $5.18 M, representing 0.00% of the portfolio. First purchased in 2012-Q4, this long-term strategic position has been held for 54 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in USNA, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2026, adding 240,218 shares. Largest reduction occurred in Q2 2014, reducing 115,800 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's USANA Health Sciences (USNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly USANA Health Sciences (USNA) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +240,218 | Add 427.42% | 296,420 | $17.47 |
| Q4 2025 | -19,625 | Reduce 25.88% | 56,202 | $19.63 |
| Q3 2025 | +61,241 | Add 419.86% | 75,827 | $27.55 |
| Q2 2025 | -7,259 | Reduce 33.23% | 14,586 | $30.53 |
| Q1 2025 | +9,894 | Add 82.79% | 21,845 | $26.97 |
| Q4 2024 | +2,765 | Add 30.10% | 11,951 | $35.89 |
| Q3 2024 | -2,242 | Reduce 19.62% | 9,186 | $37.92 |
| Q2 2024 | -3,293 | Reduce 22.37% | 11,428 | $45.24 |
| Q1 2024 | -4,559 | Reduce 23.65% | 14,721 | $48.50 |
| Q4 2023 | -20,158 | Reduce 51.11% | 19,280 | $53.60 |
| Q3 2023 | -8,280 | Reduce 17.35% | 39,438 | $58.61 |
| Q2 2023 | -4,626 | Reduce 8.84% | 47,718 | $63.04 |
| Q1 2023 | +4,378 | Add 9.13% | 52,344 | $62.90 |
| Q4 2022 | +17,763 | Add 58.81% | 47,966 | $53.20 |
| Q3 2022 | +13,457 | Add 80.36% | 30,203 | $56.05 |
| Q2 2022 | -3,575 | Reduce 17.59% | 16,746 | $72.38 |
| Q1 2022 | +395 | Add 1.98% | 20,321 | $79.47 |
| Q4 2021 | -9,749 | Reduce 32.85% | 19,926 | $101.22 |
| Q3 2021 | -4,190 | Reduce 12.37% | 29,675 | $92.20 |
| Q2 2021 | -9,219 | Reduce 21.40% | 33,865 | $102.44 |
| Q1 2021 | -7,351 | Reduce 14.58% | 43,084 | $97.60 |
| Q4 2020 | +897 | Add 1.81% | 50,435 | $77.11 |
| Q3 2020 | +4,112 | Add 9.05% | 49,538 | $73.64 |
| Q2 2020 | +1,465 | Add 3.33% | 45,426 | $73.44 |
| Q1 2020 | -85,492 | Reduce 66.04% | 43,961 | $57.76 |
| Q4 2019 | -53,730 | Reduce 29.33% | 129,453 | $78.55 |
| Q3 2019 | -62,903 | Reduce 25.56% | 183,183 | $68.39 |
| Q2 2019 | -36,388 | Reduce 12.88% | 246,086 | $79.43 |
| Q1 2019 | +9,679 | Add 3.55% | 282,474 | $83.87 |
| Q4 2018 | +31,781 | Add 13.19% | 272,795 | $117.73 |
| Q3 2018 | +78,733 | Add 48.52% | 241,014 | $120.55 |
| Q2 2018 | +87,850 | Add 118.03% | 162,281 | $115.30 |
| Q1 2018 | +12,730 | Add 20.63% | 74,431 | $85.91 |
| Q4 2017 | -3,967 | Reduce 6.04% | 61,701 | $74.05 |
| Q3 2017 | +20,987 | Add 46.97% | 65,668 | $57.70 |
| Q2 2017 | +2,533 | Add 6.01% | 44,681 | $64.10 |
| Q1 2017 | -9,876 | Reduce 18.98% | 42,148 | $57.61 |
| Q4 2016 | -14,396 | Reduce 21.67% | 52,024 | $61.20 |
| Q3 2016 | -23,044 | Reduce 25.76% | 66,420 | $69.18 |
| Q2 2016 | -16,508 | Reduce 15.58% | 89,464 | $55.71 |
| Q1 2016 | +26,432 | Add 33.23% | 105,972 | $60.71 |
| Q4 2015 | -25,724 | Reduce 24.44% | 79,540 | $63.88 |
| Q3 2015 | -40,104 | Reduce 27.59% | 105,264 | $67.01 |
| Q2 2015 | -5,354 | Reduce 3.55% | 145,368 | $68.33 |
| Q1 2015 | +62,734 | Add 71.30% | 150,722 | $55.56 |
| Q4 2014 | +53,080 | Add 152.06% | 87,988 | $51.29 |
| Q3 2014 | -42,400 | Reduce 54.85% | 34,908 | $36.84 |
| Q2 2014 | -115,800 | Reduce 59.97% | 77,308 | $39.06 |
| Q1 2014 | +600 | Add 0.31% | 193,108 | $37.67 |
| Q4 2013 | +11,650 | Add 6.44% | 192,508 | $37.79 |
| Q3 2013 | -68,136 | Reduce 27.36% | 180,858 | $43.39 |
| Q2 2013 | +248,994 | Add 0.00% | 248,994 | $36.19 |
| Q4 2012 | +188,794 | Add 0.00% | 188,794 | $16.46 |
Cliff Asness's USANA Health Sciences Investment FAQs
Cliff Asness first purchased USANA Health Sciences, Inc. (USNA) in Q4 2012, acquiring 188,794 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held USANA Health Sciences, Inc. (USNA) for 54 quarters since Q4 2012.
Cliff Asness's largest addition to USANA Health Sciences, Inc. (USNA) was in Q2 2013, adding 248,994 shares worth $9.01 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 296,420 shares of USANA Health Sciences, Inc. (USNA), valued at approximately $5.18 M.
As of the Q1 2026 filing, USANA Health Sciences, Inc. (USNA) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in USANA Health Sciences, Inc. (USNA) was 296,420 shares, as reported at the end of Q1 2026.